Centrosomal Abnormalities Characterize Human and Rodent Cystic Cholangiocytes and Are Associated with Cdc25A Overexpression-Reference-Cited by-同舟云学术

Centrosomal Abnormalities Characterize Human and Rodent Cystic Cholangiocytes and Are Associated with Cdc25A Overexpression

Published:2014-01 Issue:1 Volume:184 Page:110-121
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Masyuk Tatyana V.,Lee Seung-Ok,Radtke Brynn N.,Stroope Angela J.,Huang Bing,Banales Jesús M.,Masyuk Anatoliy I.,Splinter Patrick L.,Gradilone Sergio A.,Gajdos Gabriella B.,LaRusso Nicholas F.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference38 articles.

1. Diagnosis and management of polycystic liver disease;Gevers;Nat Rev Gastroenterol Hepatol,2013

2. Autosomal dominant polycystic kidney disease: the last 3 years;Torres;Kidney Int,2009

3. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies;Mochizuki;Clin Exp Nephrol,2013

4. Polycystic liver diseases: congenital disorders of cholangiocyte signaling;Strazzabosco;Gastroenterology,2011

5. Renal cystic disease: the role of the primary cilium/centrosome complex in pathogenesis;Siroky;Adv Chronic Kidney Dis,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting centrosome clustering reduces cystogenesis and improves kidney function in autosomal dominant polycystic kidney disease;JCI Insight;2024-02-22

2. Genetics, pathobiology and therapeutic opportunities of polycystic liver disease;Nature Reviews Gastroenterology & Hepatology;2022-05-13

3. Autophagy promotes hepatic cystogenesis in polycystic liver disease by depletion of cholangiocyte ciliogenic proteins;Hepatology;2022-02-08

4. Polycystic Liver Disease: Advances in Understanding and Treatment;Annual Review of Pathology: Mechanisms of Disease;2022-01-24

5. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease;JHEP Reports;2021-10